NDC Compounded Drug 70168-0510-1 Testosterone; Anastrozole
Pellet Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Testosterone; Anastrozole
NDC crossover of Testo100mganastrozole 4mg with NDC 70168-0510 a human compounded drug with other similar products matching the same substance name (Testosterone; Anastrozole) and the same administration route (subcutaneous) or dosage form (pellet).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
69761-222-01 | Testosterone / Anastrozole | Testosterone / Anastrozole | 1 PELLET in 1 PACKAGE | Pellet | Subcutaneous | Qualgen Llc |
69761-222-01 | Testosterone / Anastrozole | Testosterone / Anastrozole | 1 PELLET in 1 PACKAGE | Pellet | Subcutaneous | Qualgen Llc |
70168-0520-1 | Testo200mganastrozole 8mg Blnt | Testosterone/anastrozole | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
Frequently Asked Questions
What is the NDC number assigned to Testo200mganastrozole 8mg Blnt?
Testo200mganastrozole 8mg Blnt was assigned by its manufacturer with NDC product code 70168-0510. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Testo200mganastrozole 8mg Blnt?
The NDC package code 70168-0510-1 was assigned to a 1 PELLET in 1 VIAL, SINGLE-USE of testosterone; anastrozole administered subcutaneous via pellet.
Who manufactures this product?
Testo200mganastrozole 8mg Blnt is manufactured by an outsourced facility and labeled by Bso, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Qualgen LLC and BSO, LLC with NDC product codes 69761-222-01, 69761-222-01 and 70168-0520-1.